References
- Prien R F, Balter M B, Caffey E M. Hospital surveys of prescribing practices with psychotherapeutic drugs. Archives of General Psychiatry 1978; 35: 71–1275
- Nunley M. Why Indian psychiatrists prescribe so many drugs. Culture, Medicine and Psychiatry 1996; 20: 165–197
- Binder R L, Kazamatsuri H, Nishmura T, McNeil D E. Tardive dyskinesia and neuroleptic-induced parkinsonism in Japan. American Journal of Psychiatry 1987; 144: 1494–1496
- Philips M R, Lu S H, Wang R W. Economic reforms and the acute inpatient care of patients with schizophrenia. American Journal of Psychiatry 1997; 154: 1228–1234
- Lin K M, Finder E. Neuroleptic dosage in Asians. American Journal of Psychiatry 1983; 140: 490–491
- Rosenblatt R, Tang S W. Do Oriental psychiatric patients receive different dosages of psychotropic medications when compared with Occidentals. Canadian Journal of Psychiatry 1987; 32: 270–274
- Binder R L, Levy R. Extrapyramidal reactions in Asians. American Journal of Psychiatry 1981; 138: 1243–1244
- Yamamoto J, Fung D, Lo S, Reece S. Psychopharmacology for Asian Americans and Pacific islanders. Pharmacology Bulletin 1979; 15: 29–31
- American Psychiatric Association. Practice guidelines for the treatment of patients with schizophrenia. American Journal of Psychiatry 1997; 154(Suppl. 4)1–61
- Kane J M, Aguglia E, Altamura C, et al. Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology 1998; 8: 55–66
- Simpson G M, Angus J WS. A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica 1970; 212(Suppl.)11–19
- Chiu H FK, Shum P S, Lam C W. Psychotropic drug prescribing to chronic schizophrenics in a Hong Kong hospital. International Journal of Social Psychiatry 1991; 37: 187–191
- Chiu H, Lee S, Leung C M, Wing Y K. Neuroleptic prescription for Chinese schizophrenics in Hong Kong. Australian and New Zealand Journal of Psychiatry 1992; 26: 262–264
- Ko G N, Zang L D, Yan W W, et al. The Shanghai 800: prevalence of tardive dyskinesia in a Chinese psychiatric hospital. American Journal of Psychiatry 1989; 146: 387–389
- Ungvari G S, Pang A HT, Chiu H FK, Wong C K, Lum F CK. Psychotropic drug prescription in rehabilitation. A survey in Hong Kong. Social Psychiatry and Psychiatric Epidemiology 1996; 31: 288–291
- Baldessarini R J, Kando J C, Centorrino F. Hospital use of antipsychotic agents in 1989 and 1993: stable dosing with decreased length of stay. American Journal of Psychiatry 1995; 152: 1038–1044
- Reardon G T, Riftin A, Schwartz A, Myerson A, Siris S G. Changing patterns of neuroleptic dosage over a decade. American Journal of Psychiatry 1989; 46: 726–729
- Glazer W M, Kane J M. Depot neuroleptic therapy: an underutilised treatment option. Journal of Clinical Psychiatry 1996; 53: 426–433
- Johnson D AW. Depot therapy advantages, disadvantages and issues of dose. Depot antipsychotics in chronic schizophrenia., B Wistedt, J Gerlach. Excerpta Medica, Amsterdam 1991
- Gerlach J. Attitude towards the use of depot antipsychotics in several European countries. Depot antipsychotics in chronic schizophrenia., B Wistedt, J Gerlach. Excerpta Medica, Amsterdam 1991
- Owens D GC. Parkinsonism. A guide to the extrapyramidal side-effects of antipsychotic drugs. Cambridge University Press, London 1999; 68–123